piperazine, 1-methyl-4-(3-piperidinylmethyl)-
![]() |
- $75 - $1037.94
- Product name: piperazine, 1-methyl-4-(3-piperidinylmethyl)-
- CAS: 896054-84-5
- MF: C11H23N3
- MW: 197.32
- EINECS:
- MDL Number:MFCD05215168
- Synonyms:1-methyl-4-(piperidin-3-ylmethyl)piperazine trihydrochloride;piperazine, 1-methyl-4-(3-piperidinylmethyl)-;1-methyl-4-(3-piperidinylmethyl)piperazine
3 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- TRC
Package
- 500mg
- 1G
- 2.5G
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0148006
- Product description1-METHYL-4-(3-PIPERIDINYLMETHYL)PIPERAZINE 95.00%
- Packaging1G
- Price$750.68
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0148006
- Product description1-METHYL-4-(3-PIPERIDINYLMETHYL)PIPERAZINE 95.00%
- Packaging2.5G
- Price$1037.94
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberM321838
- Product description1-Methyl-4-(3-piperidinylmethyl)piperazine
- Packaging500mg
- Price$75
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | CHM0148006 | 1-METHYL-4-(3-PIPERIDINYLMETHYL)PIPERAZINE 95.00% | 1G | $750.68 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | CHM0148006 | 1-METHYL-4-(3-PIPERIDINYLMETHYL)PIPERAZINE 95.00% | 2.5G | $1037.94 | 2021-12-16 | Buy |
TRC | M321838 | 1-Methyl-4-(3-piperidinylmethyl)piperazine | 500mg | $75 | 2021-12-16 | Buy |
Properties
Boiling point :273.9±8.0 °C(Predicted)
Density :0.964±0.06 g/cm3(Predicted)
pka :10.33±0.10(Predicted)
Density :0.964±0.06 g/cm3(Predicted)
pka :10.33±0.10(Predicted)
Safety Information
Symbol(GHS): |
![]() ![]() |
|||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Danger | |||||||||||||||||||||||||||||||||||
Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
Precautionary statements: |
|